Cardinal Health, Inc. (CAH)

From the record

Cardinal Health, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Cardinal Health, Inc.'s 10 filed years say what it did: revenue went from $130 billion in fiscal 2017 to $254 billion in fiscal 2026, up 7.7% a year; it rose in 8 of 9 years; the deepest fall was 2% from fiscal 2024 to fiscal 2025; net income was positive in 8 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2026-06-30, Cardinal Health, Inc.'s diluted share count shrank about 3.3% a year, and dividends and buybacks returned about 38% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 35 sales and 0 purchases of their own stock on the open market in the year to 2026-09-30 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2026-06-30, Cardinal Health, Inc.'s shareholders' equity was below zero, so the profit on it is not read, and gross profitability: its products earned about 17 cents per dollar of everything the company owns. Leverage: it owed about 105 cents per dollar of assets, and net share issuance: its share count shrank 2.1% over the year (the filed statements).

From the record

Cardinal Health, Inc.'s standing among 10 graded names in its industry family: revenue of $254 billion in fiscal 2026 ranks in the top 25% by size; a net margin of 0.7% ranks in the top 35%; revenue growth of 7.4% a year over the last 3 filed years ranks in the bottom 45% (its annual reports).

From the record

Cardinal Health, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Hollar, Jason M. (Chief Executive Officer, as filed), filing under that title since 2023-05-17, 3.5 years (top 39% of its family); most of the 20 officers and directors filing now have filed since the record of its people begins (2022-09-06), a floor of 5.2 years the record cannot see past, so that part is not read; 6 officer or director changes were reported on Form 8-K since 2023-11-13, against the 20 people in charge now (top 17%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Cardinal Health, Inc.'s room to grow, from the newest filed statements (fiscal 2026): cash of $4.9 billion against debt of $7.0 billion leaves -3.7% of its assets as net cash, top 35% of its family; cash from operations less capital spending is 1.8% of revenue (top 35%); a gross margin of 3.8% (bottom 35%) (its annual report).

From the record

Cardinal Health, Inc.'s growth drivers, from the filed years to fiscal 2026: revenue grew 7.4% a year over the last three filed years against 7.7% over all 10, slowing (top 44% of its family); the newest year grew 14.2% (top 31%); capital spending grew 10.5% a year (top 6%) (its annual reports). Cardinal Health, Inc. reported 3 lines of business in fiscal 2025: Pharmaceutical and Specialty Solutions at $205 billion, GMPD at $13 billion, All Other at $5.4 billion. 2 of 3 grew in the latest filed year, and the largest line is 92% of revenue (its annual report).

From the record

Cardinal Health, Inc.'s newest year against its own record: revenue of $254 billion in fiscal 2026 came in 9.6% above the $232 billion its prior three years' pace pointed to (top 21% of its family); net income of $1.7 billion against a prior three-year average of $914 million (top 21%); a net margin of 0.7% against 0.4% before (top 36%) (its annual reports).